Quantitative Investment Management LLC Buys New Shares in Corteva, Inc. $CTVA

Quantitative Investment Management LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the second quarter, Holdings Channel reports. The firm purchased 16,779 shares of the company’s stock, valued at approximately $1,421,000.

Several other hedge funds have also recently added to or reduced their stakes in CTVA. EFG International AG purchased a new position in shares of Corteva during the 2nd quarter valued at about $25,000. Compass Financial Management LLC purchased a new stake in Corteva in the second quarter worth approximately $25,000. JPL Wealth Management LLC purchased a new stake in Corteva in the third quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new position in Corteva during the fourth quarter valued at approximately $27,000. Finally, Bank of Jackson Hole Trust bought a new position in Corteva during the fourth quarter valued at approximately $28,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

CTVA opened at $84.74 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The stock has a market capitalization of $56.54 billion, a PE ratio of 56.12, a price-to-earnings-growth ratio of 2.58 and a beta of 0.57. The stock’s 50 day moving average price is $82.81 and its 200-day moving average price is $80.66.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm’s revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of recent research reports. BNP Paribas Exane boosted their price objective on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Royal Bank Of Canada reaffirmed an “overweight” rating on shares of Corteva in a report on Friday. Bank of America lifted their target price on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, Mizuho raised their price objective on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.